This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, Universite Paris 7. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
2 out of 898 
2 out of 4 Years Active: 2010-2013
Title: The Innovations of Jean-Michel Betton
Introduction
Jean-Michel Betton is a notable inventor based in Paris, France, recognized for his significant contributions to the field of virology. With a focus on the severe acute respiratory syndrome (SARS), Betton has been at the forefront of research aimed at combating this deadly virus. His work not only reflects his dedication to science but also his profound impact on health and diagnostics.
Latest Patents
Jean-Michel Betton holds two patents, both centered around a novel strain of SARS-associated coronavirus, which he discovered from a sample collected in Hanoi, Vietnam. These patents encompass nucleic acid molecules originating from the genome of the coronavirus and detail proteins and peptides coded by these nucleic acid molecules, particularly focusing on protein N. The applications of this invention are varied, serving as diagnostic reagents and potential vaccine components, which play a crucial role in addressing public health challenges related to coronavirus outbreaks.
Career Highlights
Throughout his impressive career, Jean-Michel Betton has worked in esteemed research institutions, including the Centre National de la Recherche Scientifique (CNRS) and Université Paris 7. His affiliation with these prominent organizations underscores his commitment to advancing scientific understanding and innovation in virology, particularly related to coronaviruses.
Collaborations
Collaboration is essential in the field of scientific research, and Jean-Michel Betton has worked alongside notable colleagues such as Sylvie Van Der Werf and Nicolas Escriou. These partnerships have been pivotal in fostering innovative research and expanding knowledge within the scientific community, contributing to breakthroughs in the understanding of SARS and related viruses.
Conclusion
Jean-Michel Betton is a distinguished inventor whose work has significantly advanced the field of virology. With two impactful patents focused on SARS-associated coronaviruses, his contributions have the potential to influence diagnostic techniques and vaccine development. Through his collaborations and experience in prominent research institutions, Betton continues to push the boundaries of innovation in the pursuit of better health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile